Eurofins Scientific: H1 earnings up 22.4%.
(CercleFinance.com) - Eurofins Scientific has reported H1 2017 earnings that are up 22.
4% at 74.5 million euros, with adjusted EBITDA that is up 15.5% at 250.1 million euros, meaning a stable EBITDA margin of 17.9%.
Revenues increased by 15.6% to 1,397 million euros, driven by organic growth of around 6% and by over 35 acquisitions that have been signed since the beginning of the year, representing pro- forma annual revenues of over 300 million euros.
The bio-analysis services group remains confident in its 2017 target for revenues of nearly 2.9 billion euros, with adjusted EBITDA of 550 million euros, as well as its medium-term targets of 4 billion euros and 800 million euros respectively by 2020.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
4% at 74.5 million euros, with adjusted EBITDA that is up 15.5% at 250.1 million euros, meaning a stable EBITDA margin of 17.9%.
Revenues increased by 15.6% to 1,397 million euros, driven by organic growth of around 6% and by over 35 acquisitions that have been signed since the beginning of the year, representing pro- forma annual revenues of over 300 million euros.
The bio-analysis services group remains confident in its 2017 target for revenues of nearly 2.9 billion euros, with adjusted EBITDA of 550 million euros, as well as its medium-term targets of 4 billion euros and 800 million euros respectively by 2020.
Copyright (c) 2017 CercleFinance.com. All rights reserved.